Compare
Abbott Laboratories vs Stryker (ABT vs SYK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and Stryker (SYK) -8.9%; so far this year the figures are -12.3% and -7.3%.
Abbott Laboratories is the larger company by market value, about 1.5 times the size of Stryker.
On trailing earnings, ABT trades at 40.9 times and SYK at 34.7 times.
Revenue grew +10.0% at ABT and +7.9% at SYK over the last year.
ABT yields 2.29%. SYK yields 1.08%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | SYK | |
|---|---|---|
| Price | $109.93 | $325.87 |
| 1-day | -3.23% | -2.75% |
| YTD | -12.26% | -7.28% |
| 1 year | -11.73% | -8.89% |
| 3 years | +15.70% | +19.78% |
| Market cap | $190.4B | $124.1B |
| P/E | 40.9 | 34.7 |
| P/S | 3.95 | 4.72 |
| P/B | 3.73 | 5.29 |
| Revenue growth | +10.00% | +7.90% |
| EPS growth | -66.20% | +23.40% |
| Gross margin % | 56.9 | 65.3 |
| Net margin % | 9.7 | 13.8 |
| ROE % | 9.2 | 15.4 |
| Debt / equity | 0.61 | 0.64 |
| FCF yield % | 3.5 | 3.7 |
| Dividend yield % | 2.29 | 1.08 |
| Beta | 0.06 | 0.26 |
| RSI (14) | 58.5 | 61.3 |
| Technical rating |